[{"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-001", "question": "A 3-week-old male infant presents with progressive jaundice, acholic stools, and hepatomegaly. Laboratory studies reveal total bilirubin 12.4 mg/dL (direct 9.8 mg/dL), GGT 890 U/L, and ALT 156 U/L. Abdominal ultrasound shows absence of the gallbladder and a triangular cord sign at the porta hepatis. HIDA scan demonstrates good hepatic uptake but no intestinal excretion at 24 hours. Intraoperative cholangiogram confirms biliary atresia. The Kasai portoenterostomy is performed at 28 days of life. Which of the following findings at the time of surgery most strongly predicts failure to achieve bile drainage and need for liver transplantation within 2 years?", "options": ["Presence of bile duct remnants less than 150 micrometers in diameter at the porta hepatis", "Bridging fibrosis on liver biopsy without established cirrhosis", "Cytomegalovirus IgM positivity in the infant", "Splenic malformation syndrome with polysplenia", "Absence of the common bile duct with patent proximal hepatic ducts"], "answer": "A", "answer_index": 0, "explanation": "The diameter of bile duct remnants at the porta hepatis is the strongest histopathologic predictor of successful bile drainage after Kasai portoenterostomy. Remnants less than 150 micrometers are associated with poor outcomes and early transplant need. Bridging fibrosis without cirrhosis does not preclude successful drainage. CMV-associated biliary atresia and splenic malformation syndrome have variable outcomes but are not as predictive as duct remnant size. Absence of common bile duct with patent proximal ducts actually suggests a more favorable anatomy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The question asks for the strongest predictor of Kasai portoenterostomy failure requiring transplant within 2 years. Key stem clues: confirmed biliary atresia, surgical timing at 28 days. The diameter of bile duct remnants at the porta hepatis is the most validated histopathologic predictor; remnants <150 micrometers correlate with poor bile drainage and early transplant need. Option A correctly identifies this established threshold. Alternative evaluation: B (bridging fibrosis) indicates chronicity but is less predictive than duct size; C (CMV IgM) and D (splenic malformation) have variable prognostic impact; E describes favorable anatomy (patent proximal ducts) and predicts success, not failure. No logical flaws: single best answer is unambiguous, key matches it, options permit clear discrimination. Medical accuracy: The 150 micrometer cutoff is supported by decades of surgical literature and remains the gold standard prognostic criterion. All distractors are clinically relevant and appropriately differentiated. No fix required.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The question asks for the strongest predictor of Kasai portoenterostomy failure requiring transplant within 2 years. Key stem clues: confirmed biliary atresia, surgical timing at 28 days. The diameter of bile duct remnants at the porta hepatis is the most validated histopathologic predictor; remnants <150 micrometers correlate with poor bile drainage and early transplant need. Option A correctly identifies this established threshold. Alternative evaluation: B (bridging fibrosis) indicates chronicity but is less predictive than duct size; C (CMV IgM) and D (splenic malformation) have variable prognostic impact; E describes favorable anatomy (patent proximal ducts) and predicts success, not failure. No logical flaws: single best answer is unambiguous, key matches it, options permit clear discrimination. Medical accuracy: The 150 micrometer cutoff is supported by decades of surgical literature and remains the gold standard prognostic criterion. All distractors are clinically relevant and appropriately differentiated. No fix required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-002", "question": "A 34-year-old woman is brought to the emergency department after a house fire. She was found unconscious in a closed room. On arrival, she is obtunded with GCS 8. Vital signs: BP 142/88 mmHg, HR 118 bpm, RR 28/min, SpO2 98% on 100% FiO2 via non-rebreather mask. Physical examination reveals cherry-red skin coloration, no visible burns, and no soot in the oropharynx. Arterial blood gas on 100% oxygen shows pH 7.18, PaCO2 28 mmHg, PaO2 487 mmHg, lactate 14 mmol/L. Carboxyhemoglobin level is 8%. Co-oximetry reveals an additional abnormal hemoglobin species at 18%. Which of the following is the most appropriate next step in management?", "options": ["Emergent hyperbaric oxygen therapy", "Intravenous hydroxocobalamin 5 grams", "Methylene blue 1-2 mg/kg intravenously", "Exchange transfusion", "Sodium thiosulfate 12.5 grams intravenously"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation with severe lactic acidosis, obtundation, relatively low carboxyhemoglobin but an additional abnormal hemoglobin species (18% methemoglobin-like reading which actually represents cyanohemoglobin on co-oximetry) in a fire victim strongly suggests cyanide toxicity from combustion of synthetic materials. Hydroxocobalamin is the first-line antidote for cyanide poisoning as it directly binds cyanide to form cyanocobalamin. Hyperbaric oxygen addresses CO toxicity but CO level is only 8%. Methylene blue treats methemoglobinemia but is contraindicated with cyanide. Sodium thiosulfate is slower acting and used as adjunct therapy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\": \"Validity: V. Verdict: Correct best answer. Key stem clues driving cyanide toxicity diagnosis include: house fire in closed space, severe metabolic acidosis (pH 7.18, lactate 14 mmol/L), obtundation (GCS 8), and critically, relatively low carboxyhemoglobin (8%) with an additional abnormal hemoglobin species (18%) on co-oximetry representing cyanohemoglobin. Elevated lactate with high PaO2 on 100% FiO2 indicates cellular hypoxia from impaired oxygen utilization, classic for cyanide. Hydroxocobalamin 5g IV is the established first-line antidote, directly binding cyanide to form cyanocobalamin. Alternative options are correctly excluded: hyperbaric oxygen treats CO poisoning (ruled out by low COHb), methylene blue treats methemoglobinemia but is contraindicated in cyanide poisoning, exchange transfusion is not indicated, and sodium thiosulfate is slower-acting adjunct therapy. The item is logically sound with a single defensible best answer. Medical accuracy is excellent and guideline-concordant. No fixes required.\", \"medical_accuracy_score\":   \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key stem clues driving cyanide toxicity diagnosis include: house fire in closed space, severe metabolic acidosis (pH 7.18, lactate 14 mmol/L), obtundation (GCS 8), and critically, relatively low carboxyhemoglobin (8%) with an additional abnormal hemoglobin species (18%) on co-oximetry representing cyanohemoglobin. Elevated lactate with high PaO2 on 100% FiO2 indicates cellular hypoxia from impaired oxygen utilization, classic for cyanide. Hydroxocobalamin 5g IV is the established first-line antidote, directly binding cyanide to form cyanocobalamin. Alternative options are correctly excluded: hyperbaric oxygen treats CO poisoning (ruled out by low COHb), methylene blue treats methemoglobinemia but is contraindicated in cyanide poisoning, exchange transfusion is not indicated, and sodium thiosulfate is slower-acting adjunct therapy. The item is logically sound with a single defensible best answer. Medical accuracy is excellent and guideline-concordant. No fixes required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-003", "question": "A 58-year-old man with a history of chronic alcohol use disorder is undergoing emergency laparotomy for perforated duodenal ulcer. He received 4 units of packed red blood cells and 2 units of fresh frozen plasma intraoperatively. Thirty minutes after induction with propofol, fentanyl, and rocuronium, the anesthesiologist notes progressive hypotension (MAP 52 mmHg), tachycardia (128 bpm), elevated peak airway pressures (42 cmH2O), and oxygen desaturation to 88%. Central venous pressure has increased from 6 to 18 mmHg. There is no urticaria or angioedema. Bronchospasm is noted on auscultation. Serum tryptase drawn at this time returns elevated at 48 ng/mL (normal <11.4). Which of the following mechanisms most likely explains this patient's reaction?", "options": ["IgE-mediated mast cell degranulation to latex proteins", "Complement activation by anti-IgA antibodies", "Direct mast cell activation by neuromuscular blocking agent", "Bradykinin accumulation from C1-esterase inhibitor deficiency", "Transfusion-related acute lung injury from donor anti-HLA antibodies"], "answer": "C", "answer_index": 2, "explanation": "Neuromuscular blocking agents, particularly rocuronium, are the most common cause of perioperative anaphylaxis. They can cause direct (non-IgE mediated) mast cell degranulation through MRGPRX2 receptor activation, which explains the elevated tryptase, bronchospasm, and cardiovascular collapse without prior sensitization. IgA deficiency reactions typically present with urticaria and occur during transfusion. TRALI causes non-cardiogenic pulmonary edema without elevated tryptase or bronchospasm. Bradykinin-mediated angioedema does not cause bronchospasm or elevated tryptase. Latex allergy is less common and typically requires mucosal contact.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Key discriminating clues include markedly elevated serum tryptase (48 ng/mL), acute bronchospasm, and hypotension occurring 30 minutes after rocuronium administration, without urticaria. These findings point to anaphylaxis via direct mast cell activation rather than IgE-mediated sensitization. Rocuronium and other neuromuscular blocking agents are well-documented triggers of both IgE-mediated and direct MRGPRX2-mediated mast cell degranulation; the latter explains the lack of cutaneous findings and prior sensitization. Alternative options are appropriately excluded: latex allergy (A) would require mucosal contact and is less prevalent; anti-IgA reactions (B) occur during transfusion and typically present with urticaria; C1-esterase inhibitor deficiency (D) causes bradykinin-mediated angioedema without tryptase elevation or bronchospasm; TRALI (E) causes non-cardiogenic pulmonary edema from donor anti-HLA antibodies without significant tryptase release. The CVP elevation from 6 to 18 mmHg reflects acute right ventricular dysfunction from pulmonary vasoconstriction, consistent with severe anaphylaxis. The item accurately reflects current understanding of perioperative anaphylaxis mechanisms and provides sufficient discriminators for a unique best answer. No revisions required.\",\"medical_accuracy_score\":   \"5\",  \"logical_validity\":  true,  \"logical_false_reason\":  \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key discriminating clues include markedly elevated serum tryptase (48 ng/mL), acute bronchospasm, and hypotension occurring 30 minutes after rocuronium administration, without urticaria. These findings point to anaphylaxis via direct mast cell activation rather than IgE-mediated sensitization. Rocuronium and other neuromuscular blocking agents are well-documented triggers of both IgE-mediated and direct MRGPRX2-mediated mast cell degranulation; the latter explains the lack of cutaneous findings and prior sensitization. Alternative options are appropriately excluded: latex allergy (A) would require mucosal contact and is less prevalent; anti-IgA reactions (B) occur during transfusion and typically present with urticaria; C1-esterase inhibitor deficiency (D) causes bradykinin-mediated angioedema without tryptase elevation or bronchospasm; TRALI (E) causes non-cardiogenic pulmonary edema from donor anti-HLA antibodies without significant tryptase release. The CVP elevation from 6 to 18 mmHg reflects acute right ventricular dysfunction from pulmonary vasoconstriction, consistent with severe anaphylaxis. The item accurately reflects current understanding of perioperative anaphylaxis mechanisms and provides sufficient discriminators for a unique best answer. No revisions required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-004", "question": "A 72-year-old woman with severe aortic stenosis (valve area 0.6 cm², mean gradient 58 mmHg) and preserved ejection fraction is scheduled for transcatheter aortic valve replacement. During the procedure under general anesthesia, rapid ventricular pacing at 180 bpm is initiated for valve deployment. Immediately after pacing is terminated, the arterial line shows a pressure of 45/30 mmHg with a heart rate of 42 bpm. TEE reveals severe paravalvular regurgitation and a pericardial effusion of 1.8 cm with right atrial collapse. Which of the following is the most appropriate immediate intervention?", "options": ["Initiate cardiopulmonary bypass via femoral cannulation", "Administer atropine 1 mg and epinephrine 100 mcg", "Perform emergent pericardiocentesis via subxiphoid approach", "Deploy a second transcatheter valve within the first valve", "Initiate peripheral venoarterial extracorporeal membrane oxygenation"], "answer": "C", "answer_index": 2, "explanation": "The clinical picture demonstrates cardiac tamponade (pericardial effusion with right atrial collapse and profound hypotension) likely from annular rupture or wire perforation during TAVR. Emergent pericardiocentesis is the immediate life-saving intervention to relieve tamponade physiology. While VA-ECMO or cardiopulmonary bypass may ultimately be needed, pericardiocentesis can be performed immediately and may stabilize the patient. Pharmacologic support alone will not address the mechanical problem. Deploying a second valve does not address the tamponade and may worsen annular injury.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. The stem establishes cardiac tamponade physiology (hypotension 45/30 mmHg, bradycardia 42 bpm, pericardial effusion with right atrial collapse) following TAVR, likely from annular rupture. The key discriminating finding is mechanical obstruction requiring immediate drainage. Pericardiocentesis (Option C) is the definitive emergent therapy that directly relieves tamponade and can be performed immediately at bedside. Alternative analysis: A (CPB) and E (VA-ECMO) are temporizing supports that don't relieve tamponade and require setup time; B (pharmacologic support) cannot overcome mechanical obstruction; D (second valve) is irrelevant and potentially harmful. No missing details or assumptions required. The item is internally consistent with one clearly superior immediate intervention. Medical accuracy: Perfectly aligns with ACC/AHA/ESC guidelines for TAVR complications and cardiac tamponade management. The subxiphoid approach is standard emergent technique. This represents gold-standard assessment of a life-threatening procedural complication. Minimal fix: None required.\",\"medical_accuracy_score\":   \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The stem establishes cardiac tamponade physiology (hypotension 45/30 mmHg, bradycardia 42 bpm, pericardial effusion with right atrial collapse) following TAVR, likely from annular rupture. The key discriminating finding is mechanical obstruction requiring immediate drainage. Pericardiocentesis (Option C) is the definitive emergent therapy that directly relieves tamponade and can be performed immediately at bedside. Alternative analysis: A (CPB) and E (VA-ECMO) are temporizing supports that don't relieve tamponade and require setup time; B (pharmacologic support) cannot overcome mechanical obstruction; D (second valve) is irrelevant and potentially harmful. No missing details or assumptions required. The item is internally consistent with one clearly superior immediate intervention. Medical accuracy: Perfectly aligns with ACC/AHA/ESC guidelines for TAVR complications and cardiac tamponade management. The subxiphoid approach is standard emergent technique. This represents gold-standard assessment of a life-threatening procedural complication. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-005", "question": "A 28-year-old woman with treatment-resistant schizophrenia has been on clozapine 450 mg daily for 8 months with good symptom control. She presents with fever (39.2°C), sore throat, and malaise for 2 days. Laboratory studies reveal WBC 1,200/μL with absolute neutrophil count (ANC) 180/μL, hemoglobin 11.2 g/dL, and platelets 198,000/μL. Clozapine is immediately discontinued. After 14 days of supportive care including G-CSF, her ANC recovers to 2,400/μL. Given her excellent prior response to clozapine, the treatment team considers rechallenge. Which of the following factors most strongly contraindicates clozapine rechallenge in this patient?", "options": ["ANC nadir below 500/μL during the index episode", "Duration of neutropenia exceeding 10 days", "Concurrent use of G-CSF during recovery", "Time to ANC recovery exceeding 21 days from clozapine discontinuation", "Presence of fever during the neutropenic episode"], "answer": "A", "answer_index": 0, "explanation": "An ANC nadir below 500/μL (severe neutropenia/agranulocytosis) during clozapine-induced neutropenia is an absolute contraindication to rechallenge according to FDA guidelines and the Clozapine REMS program. Patients with ANC that dropped below 500/μL have a significantly higher risk of recurrent severe neutropenia with rechallenge. Duration of neutropenia, G-CSF use, recovery time, and presence of fever are concerning but do not absolutely contraindicate rechallenge if the nadir remained above 500/μL. The severity of the nadir is the critical determinant.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem establishes severe clozapine-induced neutropenia (ANC 180/μL) with fever, sore throat, and 14-day recovery on G-CSF in a patient with treatment-resistant schizophrenia. The question asks which factor most strongly contraindicates rechallenge. The critical discriminating clue is the ANC nadir <500/μL, which FDA/Clozapine REMS guidelines identify as an absolute contraindication due to prohibitive recurrence risk. While options B (duration >10 days), C (G-CSF use), and E (fever) are factually true in this case, these are secondary risk modifiers that do not absolutely contraindicate rechallenge if the nadir exceeds 500/μL. Option D is false for this patient (recovery <21 days). The item validly tests the hierarchy of rechallenge risk factors, with ANC severity being paramount. No internal contradictions or missing critical details. Medical accuracy is gold-standard: perfectly aligns with current REMS guidelines and psychiatric pharmacology consensus. The keyed answer A is uniquely defensible. Minimal fix: None required; item is board-ready.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem establishes severe clozapine-induced neutropenia (ANC 180/μL) with fever, sore throat, and 14-day recovery on G-CSF in a patient with treatment-resistant schizophrenia. The question asks which factor most strongly contraindicates rechallenge. The critical discriminating clue is the ANC nadir <500/μL, which FDA/Clozapine REMS guidelines identify as an absolute contraindication due to prohibitive recurrence risk. While options B (duration >10 days), C (G-CSF use), and E (fever) are factually true in this case, these are secondary risk modifiers that do not absolutely contraindicate rechallenge if the nadir exceeds 500/μL. Option D is false for this patient (recovery <21 days). The item validly tests the hierarchy of rechallenge risk factors, with ANC severity being paramount. No internal contradictions or missing critical details. Medical accuracy is gold-standard: perfectly aligns with current REMS guidelines and psychiatric pharmacology consensus. The keyed answer A is uniquely defensible. Minimal fix: None required; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-006", "question": "A 45-year-old man with bipolar I disorder, currently euthymic on lithium monotherapy (level 0.9 mEq/L), develops new-onset nephrotic syndrome. Renal biopsy reveals minimal change disease. His nephrologist initiates prednisone 60 mg daily. Two weeks later, he presents with decreased need for sleep, pressured speech, grandiosity, and impulsive spending. Lithium level is 0.7 mEq/L. Which of the following is the most appropriate next step in management?", "options": ["Increase lithium dose to achieve level of 1.2 mEq/L", "Add valproic acid 500 mg twice daily", "Add olanzapine 10 mg at bedtime", "Discontinue prednisone and switch to cyclosporine", "Add lamotrigine 25 mg daily with gradual titration"], "answer": "C", "answer_index": 2, "explanation": "This patient has developed corticosteroid-induced mania, a well-recognized complication of high-dose glucocorticoid therapy. The most appropriate acute intervention is adding an atypical antipsychotic such as olanzapine, which has rapid antimanic efficacy and is FDA-approved for acute mania. Increasing lithium is problematic given nephrotic syndrome and potential nephrotoxicity. Valproic acid has hepatic and hematologic concerns with concurrent steroid use. Abruptly discontinuing prednisone could cause nephrotic syndrome relapse and adrenal insufficiency. Lamotrigine has no acute antimanic efficacy and requires slow titration.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. This 45-year-old with bipolar I disorder on lithium developed classic corticosteroid-induced mania two weeks after initiating high-dose prednisone for minimal change disease. Key discriminating findings include the temporal relationship to steroids, subtherapeutic lithium level (0.7 mEq/L), and acute manic symptoms requiring rapid control. While increasing lithium (A) could address subtherapeutic levels, its slow onset and nephrotoxicity concerns in nephrotic syndrome make it inferior for acute mania. Valproic acid (B) is effective but highly protein-bound, posing free-drug toxicity risk in hypoalbuminemic nephrotic syndrome. Discontinuing prednisone (D) risks disease relapse and adrenal crisis. Lamotrigine (E) lacks acute antimanic efficacy. Olanzapine (C) provides rapid antimanic effect, is FDA-approved for acute mania, and avoids renal/hepatic concerns. The rationale correctly identifies steroid-induced mania and appropriate therapy, though its criticism of valproic acid's 'hepatic concerns with steroids' is overstated. Minor issue: the lithium level drop is unexplained but doesn't alter management. Minimal fix: Clarify that olanzapine is preferred due to rapid onset and favorable pharmacokinetics in nephrotic syndrome versus valproic acid's protein binding.\",\"medical_accuracy_score\":    \t\"4\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. This 45-year-old with bipolar I disorder on lithium developed classic corticosteroid-induced mania two weeks after initiating high-dose prednisone for minimal change disease. Key discriminating findings include the temporal relationship to steroids, subtherapeutic lithium level (0.7 mEq/L), and acute manic symptoms requiring rapid control. While increasing lithium (A) could address subtherapeutic levels, its slow onset and nephrotoxicity concerns in nephrotic syndrome make it inferior for acute mania. Valproic acid (B) is effective but highly protein-bound, posing free-drug toxicity risk in hypoalbuminemic nephrotic syndrome. Discontinuing prednisone (D) risks disease relapse and adrenal crisis. Lamotrigine (E) lacks acute antimanic efficacy. Olanzapine (C) provides rapid antimanic effect, is FDA-approved for acute mania, and avoids renal/hepatic concerns. The rationale correctly identifies steroid-induced mania and appropriate therapy, though its criticism of valproic acid's 'hepatic concerns with steroids' is overstated. Minor issue: the lithium level drop is unexplained but doesn't alter management. Minimal fix: Clarify that olanzapine is preferred due to rapid onset and favorable pharmacokinetics in nephrotic syndrome versus valproic acid's protein binding.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-007", "question": "A 32-year-old woman is brought to the psychiatric emergency department by police after being found wandering naked in a shopping mall, speaking in rhymes, and claiming to be receiving messages from television broadcasts. She has no psychiatric history. Toxicology screen is negative. Physical examination reveals a fine resting tremor, tachycardia (112 bpm), and lid lag. TSH is <0.01 mIU/L, free T4 is 6.8 ng/dL (normal 0.8-1.8), and free T3 is 18.2 pg/mL (normal 2.3-4.2). After initial stabilization with propranolol and methimazole, her psychotic symptoms persist at day 10 despite normalized heart rate. Which of the following antipsychotic medications carries the highest risk of worsening her underlying medical condition?", "options": ["Haloperidol", "Risperidone", "Quetiapine", "Aripiprazole", "Ziprasidone"], "answer": "C", "answer_index": 2, "explanation": "This patient has thyrotoxicosis-induced psychosis (thyroid storm with neuropsychiatric manifestations). Quetiapine has significant anticholinergic properties that can impair heat dissipation and worsen hyperthermia, which is particularly dangerous in thyroid storm where temperature dysregulation is already compromised. Additionally, quetiapine's alpha-adrenergic blockade can cause orthostatic hypotension, complicating the hemodynamic instability of thyrotoxicosis. Haloperidol, while having some risk of hyperthermia, has less anticholinergic activity. Risperidone, aripiprazole, and ziprasidone have minimal anticholinergic effects.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: K (Miskeyed). Verdict: The keyed answer is incorrect. In thyrotoxicosis with psychosis, haloperidol (A) carries the highest risk of precipitating neuroleptic malignant syndrome (NMS) in hypermetabolic, dehydrated patients—a well-documented and potentially fatal complication. The stem correctly establishes severe thyrotoxicosis (TSH <0.01, T4/T3 markedly elevated) with persistent psychosis despite 10 days of antithyroid therapy. The keyed answer C (quetiapine) is defended by erroneously citing 'significant anticholinergic properties' that impair heat dissipation; however, quetiapine has relatively low anticholinergic activity and is actually preferred in this setting precisely because of its lower NMS risk. Haloperidol's potent D2 antagonism and typical antipsychotic profile create the greatest danger. Medical accuracy score is 2 due to major factual errors that mislead learners about drug safety profiles and risks. Logical validity fails because the key doesn't match the clinically correct answer. Minimal fix: Change key to A and rewrite rationale to emphasize NMS risk with high-potency typical antipsychotics in hypermetabolic states, while noting quetiapine's relatively favorable safety profile.\",\"medical_accuracy_score\":   \t\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: K (Miskeyed). Verdict: The keyed answer is incorrect. In thyrotoxicosis with psychosis, haloperidol (A) carries the highest risk of precipitating neuroleptic malignant syndrome (NMS) in hypermetabolic, dehydrated patients—a well-documented and potentially fatal complication. The stem correctly establishes severe thyrotoxicosis (TSH <0.01, T4/T3 markedly elevated) with persistent psychosis despite 10 days of antithyroid therapy. The keyed answer C (quetiapine) is defended by erroneously citing 'significant anticholinergic properties' that impair heat dissipation; however, quetiapine has relatively low anticholinergic activity and is actually preferred in this setting precisely because of its lower NMS risk. Haloperidol's potent D2 antagonism and typical antipsychotic profile create the greatest danger. Medical accuracy score is 2 due to major factual errors that mislead learners about drug safety profiles and risks. Logical validity fails because the key doesn't match the clinically correct answer. Minimal fix: Change key to A and rewrite rationale to emphasize NMS risk with high-potency typical antipsychotics in hypermetabolic states, while noting quetiapine's relatively favorable safety profile.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-008", "question": "A 67-year-old man undergoes elective right hemicolectomy for a cecal adenocarcinoma. On postoperative day 3, he develops fever (38.9°C), tachycardia, and diffuse abdominal tenderness with guarding. CT scan reveals free air, a 4-cm fluid collection near the ileocolic anastomosis, and no contrast extravasation on oral contrast study. Laboratory studies show WBC 18,400/μL and lactate 3.2 mmol/L. At re-exploration, the anastomosis appears intact but edematous with surrounding fibrinous exudate. There is 400 mL of turbid fluid in the peritoneal cavity. Gram stain of the fluid shows gram-negative rods and gram-positive cocci in chains. Which of the following is the most appropriate surgical management?", "options": ["Washout with drain placement and preservation of anastomosis", "Takedown of anastomosis with end ileostomy and mucous fistula", "Takedown of anastomosis with end ileostomy and Hartmann's pouch", "Resection of anastomosis with primary re-anastomosis and proximal diverting loop ileostomy", "Washout with omental patch reinforcement of anastomosis"], "answer": "B", "answer_index": 1, "explanation": "This patient has an anastomotic leak with peritonitis despite the anastomosis appearing grossly intact (contained leak with surrounding contamination). In the setting of generalized peritonitis, hemodynamic compromise (tachycardia, elevated lactate), and polymicrobial contamination, the safest approach is takedown of the anastomosis with end ileostomy and mucous fistula. This is preferred over Hartmann's pouch because the distal bowel (ascending/transverse colon) is healthy and can be exteriorized. Preserving the anastomosis or performing primary re-anastomosis in this contaminated, inflamed field carries unacceptable leak risk.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. Key stem clues driving the decision include postoperative day 3 presentation, diffuse abdominal tenderness with guarding indicating generalized peritonitis, tachycardia with lactate 3.2 suggesting systemic sepsis, polymicrobial Gram stain of turbid fluid confirming intra-abdominal contamination, and intraoperative findings of an edematous anastomosis with fibrinous exudate. These findings collectively mandate anastomotic takedown rather than preservation. The distinction between options B (mucous fistula) and C (Hartmann's pouch) rests on the standard surgical principle that healthy distal bowel should be exteriorized when feasible to facilitate future restoration of continuity without repeat laparotomy. The stem's context of right hemicolectomy for cecal adenocarcinoma implies a healthy transverse colon distal to the ileocolic anastomosis, making B uniquely defensible as the most appropriate choice. Options A and E are too conservative for generalized peritonitis, while D is contraindicated in a contaminated, inflamed field. No logical contradictions or medical inaccuracies are present; the item accurately reflects current surgical management guidelines for anastomotic leaks. Minimal fix: none required.\",\"medical_accuracy_score\":   \"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues driving the decision include postoperative day 3 presentation, diffuse abdominal tenderness with guarding indicating generalized peritonitis, tachycardia with lactate 3.2 suggesting systemic sepsis, polymicrobial Gram stain of turbid fluid confirming intra-abdominal contamination, and intraoperative findings of an edematous anastomosis with fibrinous exudate. These findings collectively mandate anastomotic takedown rather than preservation. The distinction between options B (mucous fistula) and C (Hartmann's pouch) rests on the standard surgical principle that healthy distal bowel should be exteriorized when feasible to facilitate future restoration of continuity without repeat laparotomy. The stem's context of right hemicolectomy for cecal adenocarcinoma implies a healthy transverse colon distal to the ileocolic anastomosis, making B uniquely defensible as the most appropriate choice. Options A and E are too conservative for generalized peritonitis, while D is contraindicated in a contaminated, inflamed field. No logical contradictions or medical inaccuracies are present; the item accurately reflects current surgical management guidelines for anastomotic leaks. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-009", "question": "A 52-year-old woman with BMI 48 kg/m² undergoes laparoscopic Roux-en-Y gastric bypass. Eighteen months postoperatively, she has lost 95 pounds and presents with recurrent episodes of postprandial confusion, diaphoresis, and tremor that resolve with eating. Symptoms occur 2-3 hours after meals, particularly those high in simple carbohydrates. Fasting glucose is 78 mg/dL. A mixed meal tolerance test demonstrates glucose of 42 mg/dL with insulin of 28 μU/mL and C-peptide of 6.2 ng/mL at 120 minutes. Calcium-stimulated angiography and selective arterial calcium stimulation testing are negative for insulinoma. Which of the following is the most appropriate next step in management?", "options": ["Diazoxide 100 mg three times daily", "Octreotide 100 mcg subcutaneously before meals", "Acarbose 50 mg with meals", "Completion pancreatectomy", "Reversal of gastric bypass to normal anatomy"], "answer": "C", "answer_index": 2, "explanation": "This patient has post-bariatric hypoglycemia (previously called late dumping syndrome or noninsulinoma pancreatogenous hypoglycemia syndrome). The pathophysiology involves exaggerated GLP-1 secretion leading to inappropriate insulin release after rapid glucose absorption. Acarbose, an alpha-glucosidase inhibitor, slows carbohydrate absorption and reduces the glycemic spike that triggers excessive insulin secretion. It is first-line medical therapy. Diazoxide and octreotide are second-line options with more side effects. Pancreatectomy is reserved for refractory cases. Reversal surgery has high morbidity and variable efficacy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues driving a unique answer: Roux-en-Y gastric bypass, postprandial neuroglycopenia 2–3 hours after high-carbohydrate meals, inappropriately elevated insulin (28 μU/mL) and C-peptide (6.2 ng/mL) during documented hypoglycemia (42 mg/dL) on mixed meal testing, and negative selective arterial calcium stimulation studies—together diagnostic of post-bariatric hypoglycemia (PBH). Acarbose (C) is the most appropriate next step as it is first-line medical therapy that blunts the pathologic GLP-1–mediated hyperinsulinemic response by delaying carbohydrate absorption. Alternative options are correctly positioned as less appropriate: diazoxide (A) and octreotide (B) are second-line due to adverse effect burden; completion pancreatectomy (D) is reserved for refractory disease; reversal (E) has high morbidity and variable efficacy. No logical contradictions or underspecification. Medical accuracy is gold-standard: pathophysiology and management hierarchy align with current endocrine society consensus. Minimal fix: None required.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues driving a unique answer: Roux-en-Y gastric bypass, postprandial neuroglycopenia 2–3 hours after high-carbohydrate meals, inappropriately elevated insulin (28 μU/mL) and C-peptide (6.2 ng/mL) during documented hypoglycemia (42 mg/dL) on mixed meal testing, and negative selective arterial calcium stimulation studies—together diagnostic of post-bariatric hypoglycemia (PBH). Acarbose (C) is the most appropriate next step as it is first-line medical therapy that blunts the pathologic GLP-1–mediated hyperinsulinemic response by delaying carbohydrate absorption. Alternative options are correctly positioned as less appropriate: diazoxide (A) and octreotide (B) are second-line due to adverse effect burden; completion pancreatectomy (D) is reserved for refractory disease; reversal (E) has high morbidity and variable efficacy. No logical contradictions or underspecification. Medical accuracy is gold-standard: pathophysiology and management hierarchy align with current endocrine society consensus. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-010", "question": "A 58-year-old man with type 2 diabetes presents with sudden painless vision loss in his right eye upon awakening. Best-corrected visual acuity is 20/200 OD and 20/25 OS. Funduscopic examination of the right eye reveals diffuse retinal whitening with a cherry-red spot at the macula, attenuated arterioles, and segmentation of blood columns (\"boxcarring\"). Intraocular pressure is 14 mmHg OD and 15 mmHg OS. Carotid duplex shows 40% stenosis of the right internal carotid artery. Echocardiogram reveals no intracardiac thrombus. The patient presents 3 hours after symptom onset. Which of the following interventions has the strongest evidence for visual recovery in this condition?", "options": ["Anterior chamber paracentesis to lower intraocular pressure", "Intravenous tissue plasminogen activator", "Hyperbaric oxygen therapy", "Intra-arterial thrombolysis via ophthalmic artery catheterization", "Conservative management with secondary stroke prevention"], "answer": "E", "answer_index": 4, "explanation": "This patient has central retinal artery occlusion (CRAO). Despite numerous proposed interventions including ocular massage, anterior chamber paracentesis, carbogen inhalation, IV or intra-arterial thrombolysis, and hyperbaric oxygen, no treatment has demonstrated consistent efficacy in randomized controlled trials for improving visual outcomes in CRAO. The EAGLE study found no benefit of intra-arterial thrombolysis. Current evidence supports conservative management with urgent evaluation and treatment for stroke risk factors, as CRAO is considered a stroke equivalent. Secondary prevention with antiplatelet therapy and risk factor modification is the evidence-based approach.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\": \"Validity: N (No answer defensible). The vignette describes classic central retinal artery occlusion (CRAO). The question asks which intervention has strongest evidence for visual recovery. Options A-D represent acute reperfusion therapies without proven efficacy: anterior chamber paracentesis lacks RCT support; IV tPA is not indicated; hyperbaric oxygen has limited evidence; intra-arterial thrombolysis was negative in EAGLE. Option E addresses secondary stroke prevention, not visual recovery. This creates a fatal mismatch—no option actually answers the question posed. While conservative management is evidence-based for CRAO as a stroke equivalent, it does not confer visual recovery. The question requires an unstated assumption that 'best evidence' means 'best overall management' rather than literal visual recovery. All acute interventions are equally indefensible, and option E is categorically misaligned with the query. Medical accuracy is high regarding CRAO pathophysiology and trial data, but the item construction is logically invalid. Fix: Change stem to 'Which is the most appropriate management?' or add option F: 'None of the above' and rekey to F.\", \"medical_accuracy_score\":    \t\"4\", \"logical_validity\": false, \"logical_false_reason\": \"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: N (No answer defensible). The vignette describes classic central retinal artery occlusion (CRAO). The question asks which intervention has strongest evidence for visual recovery. Options A-D represent acute reperfusion therapies without proven efficacy: anterior chamber paracentesis lacks RCT support; IV tPA is not indicated; hyperbaric oxygen has limited evidence; intra-arterial thrombolysis was negative in EAGLE. Option E addresses secondary stroke prevention, not visual recovery. This creates a fatal mismatch—no option actually answers the question posed. While conservative management is evidence-based for CRAO as a stroke equivalent, it does not confer visual recovery. The question requires an unstated assumption that 'best evidence' means 'best overall management' rather than literal visual recovery. All acute interventions are equally indefensible, and option E is categorically misaligned with the query. Medical accuracy is high regarding CRAO pathophysiology and trial data, but the item construction is logically invalid. Fix: Change stem to 'Which is the most appropriate management?' or add option F: 'None of the above' and rekey to F.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-011", "question": "A 6-year-old boy presents with progressive gait instability, frequent falls, and difficulty climbing stairs over the past year. Physical examination reveals calf pseudohypertrophy, positive Gowers' sign, and proximal muscle weakness. Creatine kinase is 15,400 U/L. Genetic testing confirms a deletion in the dystrophin gene consistent with Duchenne muscular dystrophy. Echocardiogram shows normal left ventricular function. The family asks about disease-modifying therapy. The child weighs 22 kg. Which of the following treatments is most likely to slow disease progression in this patient?", "options": ["Deflazacort 0.9 mg/kg/day", "Eteplirsen 30 mg/kg weekly intravenously", "Ataluren 40 mg/kg/day in three divided doses", "Golodirsen 30 mg/kg weekly intravenously", "Idebenone 900 mg daily"], "answer": "A", "answer_index": 0, "explanation": "Deflazacort (and prednisone) are the only treatments with robust evidence demonstrating slowed disease progression in Duchenne muscular dystrophy, including prolonged ambulation, preserved pulmonary function, and delayed cardiomyopathy. Deflazacort may have a slightly better side effect profile than prednisone. Exon-skipping therapies (eteplirsen, golodirsen) are only applicable to specific mutations amenable to exon skipping and have shown only modest dystrophin production without clear clinical benefit. Ataluren is for nonsense mutations only. Idebenone showed no benefit in the DELOS trial for patients on corticosteroids.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. Key stem clues: 6-year-old with confirmed DMD due to dystrophin gene DELETION, normal cardiac function, weight 22kg. The question seeks the disease-modifying therapy most likely to slow progression. Deflazacort (A) is the standard of care for all DMD patients with robust evidence for prolonging ambulation and delaying cardiomyopathy; dose 0.9 mg/kg/day is appropriate for 22kg child. Alternative analysis: Eteplirsen (B) and Golodirsen (D) require specific deletion patterns amenable to exon 51/53 skipping—not stated—and show only modest dystrophin production without clear clinical benefit; Ataluren (C) is for nonsense mutations only, not deletions; Idebenone (E) lacks proven benefit per DELOS trial. No logical issues: stem provides sufficient discrimination as corticosteroids are universally recommended while alternatives are mutation-restricted or ineffective. Medical accuracy is gold-standard: aligns with current neuromuscular guidelines and accurately reflects evidence hierarchy. Minimal fix: None required; item is board-ready.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues: 6-year-old with confirmed DMD due to dystrophin gene DELETION, normal cardiac function, weight 22kg. The question seeks the disease-modifying therapy most likely to slow progression. Deflazacort (A) is the standard of care for all DMD patients with robust evidence for prolonging ambulation and delaying cardiomyopathy; dose 0.9 mg/kg/day is appropriate for 22kg child. Alternative analysis: Eteplirsen (B) and Golodirsen (D) require specific deletion patterns amenable to exon 51/53 skipping—not stated—and show only modest dystrophin production without clear clinical benefit; Ataluren (C) is for nonsense mutations only, not deletions; Idebenone (E) lacks proven benefit per DELOS trial. No logical issues: stem provides sufficient discrimination as corticosteroids are universally recommended while alternatives are mutation-restricted or ineffective. Medical accuracy is gold-standard: aligns with current neuromuscular guidelines and accurately reflects evidence hierarchy. Minimal fix: None required; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-012", "question": "A 24-year-old man is brought to the emergency department after being rescued from a house fire. He has extensive full-thickness burns covering an estimated 65% total body surface area. He is intubated in the field for airway protection. Initial resuscitation is begun with lactated Ringer's solution using the Parkland formula. Six hours into resuscitation, he has received 14 liters of crystalloid. Vital signs: BP 88/52 mmHg, HR 132 bpm. Urine output over the past 2 hours is 15 mL total. Bladder pressure is 32 mmHg. Peak airway pressures have increased from 28 to 48 cmH2O. Which of the following is the most appropriate next step?", "options": ["Increase crystalloid infusion rate by 50%", "Add albumin 5% to resuscitation fluids", "Perform bilateral chest escharotomies", "Perform decompressive laparotomy", "Perform bedside abdominal escharotomy"], "answer": "E", "answer_index": 4, "explanation": "This patient has developed abdominal compartment syndrome (ACS) in the setting of massive burn resuscitation, evidenced by oliguria, hypotension, elevated bladder pressure (>20 mmHg with organ dysfunction), and elevated airway pressures. In burn patients with circumferential or near-circumferential truncal burns, abdominal escharotomy can effectively decompress the abdomen without the morbidity of laparotomy. This should be attempted before decompressive laparotomy. Increasing crystalloid will worsen edema and compartment pressures. Chest escharotomies address thoracic restriction but not abdominal compartment syndrome. Albumin may reduce total fluid requirements but won't acutely address ACS.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: M (Multiple answers defensible), secondary U. Verdict: Not uniquely determinable. The stem establishes abdominal compartment syndrome (ACS) with bladder pressure 32 mmHg, oliguria, hypotension, and rising airway pressures after 14L crystalloid resuscitation for 65% TBSA burns. However, it omits the critical detail of whether truncal burns are circumferential—the key factor determining abdominal escharotomy efficacy. While keyed answer E is appropriate for restrictive eschar, option D (decompressive laparotomy) is equally defensible for primary ACS when escharotomy is not applicable or fails. This makes both options plausible depending on unstated assumptions, violating single-best-answer principle. The rationale correctly outlines the management hierarchy but cannot be applied. Medical accuracy is otherwise sound regarding ACS pathophysiology and treatment options. Score: 3 (minor issues due to critical omission). Minimal fix: Add 'with circumferential truncal burns' to the stem.\",\"medical_accuracy_score\":   \"3\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: M (Multiple answers defensible), secondary U. Verdict: Not uniquely determinable. The stem establishes abdominal compartment syndrome (ACS) with bladder pressure 32 mmHg, oliguria, hypotension, and rising airway pressures after 14L crystalloid resuscitation for 65% TBSA burns. However, it omits the critical detail of whether truncal burns are circumferential—the key factor determining abdominal escharotomy efficacy. While keyed answer E is appropriate for restrictive eschar, option D (decompressive laparotomy) is equally defensible for primary ACS when escharotomy is not applicable or fails. This makes both options plausible depending on unstated assumptions, violating single-best-answer principle. The rationale correctly outlines the management hierarchy but cannot be applied. Medical accuracy is otherwise sound regarding ACS pathophysiology and treatment options. Score: 3 (minor issues due to critical omission). Minimal fix: Add 'with circumferential truncal burns' to the stem.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-013", "question": "A 45-year-old woman with myasthenia gravis (anti-acetylcholine receptor antibody positive) on pyridostigmine and prednisone is scheduled for thymectomy. She reports mild dyspnea with exertion and occasional dysphagia. Forced vital capacity is 1.8 L (62% predicted). On the morning of surgery, she takes her usual pyridostigmine dose. After uneventful induction with propofol and fentanyl, the anesthesiologist administers rocuronium 0.6 mg/kg for intubation. The surgery proceeds without complication. At the end of the case, train-of-four monitoring shows 2/4 twitches. Sugammadex 4 mg/kg is administered. Five minutes later, train-of-four ratio is 0.95 and the patient is extubated. In the PACU, she develops progressive respiratory distress, paradoxical breathing, and oxygen desaturation. ABG shows pH 7.28, PaCO2 62 mmHg, PaO2 58 mmHg on 6L nasal cannula. Which of the following is the most likely cause of her respiratory failure?", "options": ["Residual neuromuscular blockade from rocuronium", "Sugammadex-induced anaphylaxis", "Myasthenic crisis precipitated by surgical stress", "Cholinergic crisis from pyridostigmine", "Unilateral phrenic nerve injury during thymectomy"], "answer": "C", "answer_index": 2, "explanation": "This patient is experiencing myasthenic crisis, an exacerbation of myasthenia gravis causing respiratory failure. Surgical stress, particularly thymectomy, is a well-known precipitant. The adequate train-of-four ratio (0.95) after sugammadex rules out residual neuromuscular blockade. Sugammadex anaphylaxis would present with cardiovascular collapse and bronchospasm, not isolated hypercapnic respiratory failure. Cholinergic crisis would present with excessive secretions, miosis, bradycardia, and fasciculations. Unilateral phrenic nerve injury rarely causes this degree of respiratory compromise. The hypercapnic respiratory failure pattern indicates neuromuscular weakness affecting respiratory muscles.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Key stem clues: (1) established myasthenia gravis with baseline respiratory weakness (FVC 62% predicted); (2) thymectomy as surgical stress trigger; (3) definitive exclusion of residual neuromuscular blockade via quantitative train-of-four ratio 0.95 after appropriate sugammadex dosing; (4) hypercapnic respiratory failure pattern (PaCO2 62 mmHg) characteristic of neuromuscular respiratory insufficiency. Option C (myasthenic crisis) is uniquely defensible as surgical stress is a recognized precipitant, and the clinical picture aligns with exacerbated weakness. Alternatives are appropriately eliminated: A contradicts objective reversal data; B would manifest with cardiovascular collapse and bronchospasm; D would show cholinergic excess signs (secretions, bradycardia, miosis) not present; E rarely produces such severe hypercapnia and would have radiographic evidence. No logical contradictions or critical omissions. Medical content is accurate and consistent with perioperative MG management guidelines. Minimal fix: None required; item is board-ready.\",\"medical_accuracy_score\":   \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key stem clues: (1) established myasthenia gravis with baseline respiratory weakness (FVC 62% predicted); (2) thymectomy as surgical stress trigger; (3) definitive exclusion of residual neuromuscular blockade via quantitative train-of-four ratio 0.95 after appropriate sugammadex dosing; (4) hypercapnic respiratory failure pattern (PaCO2 62 mmHg) characteristic of neuromuscular respiratory insufficiency. Option C (myasthenic crisis) is uniquely defensible as surgical stress is a recognized precipitant, and the clinical picture aligns with exacerbated weakness. Alternatives are appropriately eliminated: A contradicts objective reversal data; B would manifest with cardiovascular collapse and bronchospasm; D would show cholinergic excess signs (secretions, bradycardia, miosis) not present; E rarely produces such severe hypercapnia and would have radiographic evidence. No logical contradictions or critical omissions. Medical content is accurate and consistent with perioperative MG management guidelines. Minimal fix: None required; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-014", "question": "A 68-year-old man with severe COPD (FEV1 28% predicted) undergoes right upper lobectomy for non-small cell lung cancer under general anesthesia with one-lung ventilation using a left-sided double-lumen tube. During one-lung ventilation of the left lung, SpO2 drops to 84% despite FiO2 1.0. Fiberoptic bronchoscopy confirms correct tube position. Tidal volume is 350 mL, respiratory rate 14/min, PEEP 5 cmH2O. Peak airway pressure is 38 cmH2O. ABG shows PaO2 52 mmHg, PaCO2 58 mmHg. Which of the following interventions is most likely to improve oxygenation?", "options": ["Apply CPAP 5 cmH2O to the non-ventilated (operative) lung", "Increase PEEP to 10 cmH2O on the ventilated lung", "Increase tidal volume to 500 mL", "Administer inhaled nitric oxide to the ventilated lung", "Clamp the pulmonary artery of the operative lung"], "answer": "A", "answer_index": 0, "explanation": "Hypoxemia during one-lung ventilation results primarily from shunt through the non-ventilated lung. Applying CPAP (typically 5-10 cmH2O) to the non-ventilated lung provides oxygen to the collapsed lung and recruits some alveoli, reducing shunt fraction while minimally interfering with surgical exposure. Increasing PEEP on the ventilated lung may overdistend already hyperinflated COPD lung and divert blood flow to the non-ventilated lung, worsening shunt. Increasing tidal volume risks barotrauma. Inhaled nitric oxide to the ventilated lung improves V/Q matching but is less effective than addressing the shunt directly. Pulmonary artery clamping is invasive and typically reserved for pneumonectomy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V. Verdict: Correct best answer. This OLV hypoxemia vignette features a 68-year-old with severe COPD (FEV1 28%) during right upper lobectomy, with SpO2 84% on FiO2 1.0 and confirmed correct tube position. Key discriminating findings: shunt physiology (PaO2 52 mmHg) through the non-ventilated lung, hyperinflated COPD physiology, and already-elevated peak airway pressure (38 cmH2O). The question asks for the most effective oxygenation intervention. Option A (CPAP 5 cmH2O to operative lung) directly reduces shunt by oxygenating and recruiting collapsed alveoli, representing standard first-line management with minimal surgical impact. Option B would overdistend the hyperinflated COPD lung, increase PVR, and worsen shunt. Option C risks barotrauma/volutrauma at high pressures. Option D is less effective as it doesn't address the primary shunt. Option E is excessively invasive for lobectomy. The COPD detail appropriately eliminates alternatives. No contradictions or critical omissions. Medical accuracy is excellent and board-relevant. Minor enhancement: Specify patient weight to confirm lung-protective ventilation, though implied.\",\n\"medical_accuracy_score\":   \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. This OLV hypoxemia vignette features a 68-year-old with severe COPD (FEV1 28%) during right upper lobectomy, with SpO2 84% on FiO2 1.0 and confirmed correct tube position. Key discriminating findings: shunt physiology (PaO2 52 mmHg) through the non-ventilated lung, hyperinflated COPD physiology, and already-elevated peak airway pressure (38 cmH2O). The question asks for the most effective oxygenation intervention. Option A (CPAP 5 cmH2O to operative lung) directly reduces shunt by oxygenating and recruiting collapsed alveoli, representing standard first-line management with minimal surgical impact. Option B would overdistend the hyperinflated COPD lung, increase PVR, and worsen shunt. Option C risks barotrauma/volutrauma at high pressures. Option D is less effective as it doesn't address the primary shunt. Option E is excessively invasive for lobectomy. The COPD detail appropriately eliminates alternatives. No contradictions or critical omissions. Medical accuracy is excellent and board-relevant. Minor enhancement: Specify patient weight to confirm lung-protective ventilation, though implied.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-015", "question": "A 35-year-old woman with no psychiatric history presents with acute onset of bizarre behavior, visual hallucinations, and seizures over 3 days. She has no fever. MRI brain shows bilateral medial temporal lobe T2 hyperintensities. CSF analysis reveals lymphocytic pleocytosis (45 cells/μL), elevated protein (68 mg/dL), and normal glucose. EEG shows extreme delta brush pattern. Anti-NMDA receptor antibodies return positive in CSF. CT of chest, abdomen, and pelvis reveals a 4-cm right ovarian mass. After tumor resection (pathology confirms ovarian teratoma), she receives first-line immunotherapy with high-dose corticosteroids, IVIG, and plasmapheresis. At week 6, she remains comatose with persistent seizures. Which of the following is the most appropriate next step in management?", "options": ["Continue current immunotherapy regimen for additional 6 weeks", "Initiate rituximab 375 mg/m² weekly for 4 doses", "Initiate cyclophosphamide 750 mg/m² monthly", "Initiate rituximab and cyclophosphamide combination therapy", "Initiate intrathecal methotrexate"], "answer": "D", "answer_index": 3, "explanation": "Anti-NMDA receptor encephalitis refractory to first-line therapy (tumor removal, corticosteroids, IVIG, and/or plasmapheresis) requires escalation to second-line immunotherapy. Current evidence and expert consensus support combination rituximab and cyclophosphamide as second-line therapy for refractory cases, as this combination targets both B-cell mediated antibody production and provides broader immunosuppression. Using either agent alone is less effective in severe refractory cases. Continuing first-line therapy alone when there is no response at 6 weeks delays effective treatment. Intrathecal methotrexate is not standard therapy for autoimmune encephalitis.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\": \"Validity: V (Valid). Verdict: Correct best answer. This stem clearly describes severe, refractory anti-NMDA receptor encephalitis with persistent coma and seizures despite 6 weeks of complete first-line therapy (tumor resection, steroids, IVIG, plasmapheresis). Key discriminating findings include: anti-NMDA receptor antibody positivity, lack of clinical improvement, and severe neurological status. The question appropriately tests escalation to second-line immunotherapy. While rituximab monotherapy (Option B) is a reasonable second-line option, the combination regimen (Option D) is defensible as most appropriate for this severe refractory presentation. Options A and E are clearly incorrect per standard guidelines. The rationale correctly identifies that continuing first-line therapy alone would delay effective treatment and that intrathecal methotrexate is not standard. Medical accuracy is sound: the presentation, diagnostic workup, and treatment sequencing align with current consensus (Lancet Neurology 2016, Neurotherapeutics 2020). The preference for combination therapy in severe refractory cases is supported by expert opinion and emerging evidence, though rituximab alone remains acceptable practice. Minor issue: the superiority of combination over single-agent rituximab is not universally established as first second-line step. Minimal fix: Add \\\"with severe disease\\\" to the stem to explicitly justify combination therapy over monotherapy.\", \"medical_accuracy_score\":    \t\"4\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. This stem clearly describes severe, refractory anti-NMDA receptor encephalitis with persistent coma and seizures despite 6 weeks of complete first-line therapy (tumor resection, steroids, IVIG, plasmapheresis). Key discriminating findings include: anti-NMDA receptor antibody positivity, lack of clinical improvement, and severe neurological status. The question appropriately tests escalation to second-line immunotherapy. While rituximab monotherapy (Option B) is a reasonable second-line option, the combination regimen (Option D) is defensible as most appropriate for this severe refractory presentation. Options A and E are clearly incorrect per standard guidelines. The rationale correctly identifies that continuing first-line therapy alone would delay effective treatment and that intrathecal methotrexate is not standard. Medical accuracy is sound: the presentation, diagnostic workup, and treatment sequencing align with current consensus (Lancet Neurology 2016, Neurotherapeutics 2020). The preference for combination therapy in severe refractory cases is supported by expert opinion and emerging evidence, though rituximab alone remains acceptable practice. Minor issue: the superiority of combination over single-agent rituximab is not universally established as first second-line step. Minimal fix: Add \"with severe disease\" to the stem to explicitly justify combination therapy over monotherapy.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-016", "question": "A 72-year-old man with major depressive disorder has failed adequate trials of sertraline, venlafaxine, and mirtazapine augmented with aripiprazole. He has no psychotic features. Medical history includes coronary artery disease with drug-eluting stent placed 8 months ago (on aspirin and clopidogrel), hypertension, and benign prostatic hyperplasia. He is referred for electroconvulsive therapy (ECT). Pre-ECT cardiac evaluation shows EF 55% with no active ischemia. Which of the following medication adjustments is most appropriate before initiating ECT?", "options": ["Discontinue clopidogrel 7 days before first ECT session", "Hold aspirin on the morning of each ECT session", "Continue dual antiplatelet therapy without modification", "Bridge with enoxaparin after stopping clopidogrel", "Switch clopidogrel to ticagrelor for shorter half-life"], "answer": "C", "answer_index": 2, "explanation": "Current evidence and guidelines support continuing dual antiplatelet therapy (DAPT) during ECT. The risk of stent thrombosis from discontinuing antiplatelet therapy within 12 months of drug-eluting stent placement significantly outweighs the minimal bleeding risk associated with ECT. ECT does not involve surgical incisions, and intracranial hemorrhage during ECT is exceedingly rare even on anticoagulation. Discontinuing or bridging antiplatelet therapy is not recommended. The transient hypertension during ECT seizure is manageable with appropriate anesthetic technique and does not contraindicate the procedure in stable coronary disease.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict: Correct best answer. Key stem clues driving the decision: drug-eluting stent placed 8 months ago (within critical 12-month DAPT window), current dual antiplatelet therapy with aspirin and clopidogrel, and stable cardiac status (EF 55%, no ischemia). The question asks for most appropriate medication adjustment before ECT. Current cardiology guidelines mandate continuation of DAPT for 12 months post-DES to prevent stent thrombosis, a risk that far outweighs ECT's minimal bleeding risk. ECT does not involve surgical incisions, and intracranial hemorrhage is exceedingly rare even with antithrombotic therapy. Option C aligns perfectly with this evidence-based standard. Alternative analysis: A and D incorrectly propose stopping/clopidogrel, risking catastrophic stent thrombosis; B unnecessarily withholds aspirin without justification; E offers no clinical advantage while adding cost and complexity. No logical flaws: the stem provides sufficient detail, options are mutually exclusive and collectively exhaustive, and the key is unambiguously supported. Medical accuracy is excellent—consistent with ACC/AHA and APA ECT guidelines. Minimal fix: none required; item is board-ready.\",\"medical_accuracy_score\":    \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: Correct best answer. Key stem clues driving the decision: drug-eluting stent placed 8 months ago (within critical 12-month DAPT window), current dual antiplatelet therapy with aspirin and clopidogrel, and stable cardiac status (EF 55%, no ischemia). The question asks for most appropriate medication adjustment before ECT. Current cardiology guidelines mandate continuation of DAPT for 12 months post-DES to prevent stent thrombosis, a risk that far outweighs ECT's minimal bleeding risk. ECT does not involve surgical incisions, and intracranial hemorrhage is exceedingly rare even with antithrombotic therapy. Option C aligns perfectly with this evidence-based standard. Alternative analysis: A and D incorrectly propose stopping/clopidogrel, risking catastrophic stent thrombosis; B unnecessarily withholds aspirin without justification; E offers no clinical advantage while adding cost and complexity. No logical flaws: the stem provides sufficient detail, options are mutually exclusive and collectively exhaustive, and the key is unambiguously supported. Medical accuracy is excellent—consistent with ACC/AHA and APA ECT guidelines. Minimal fix: none required; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-017", "question": "A 19-year-old college student is brought to the emergency department by campus police after being found in her dormitory room with superficial lacerations on both forearms. She reports cutting herself \"to feel something\" after her boyfriend ended their 2-month relationship. She denies suicidal ideation and states she \"would never actually kill herself.\" She describes a pattern of intense, unstable relationships, chronic feelings of emptiness, and impulsive behaviors including binge eating and reckless driving. She has had multiple similar presentations over the past 3 years. Mental status examination reveals dramatic affect with rapid shifts between tearfulness and anger. Which of the following is the most appropriate disposition?", "options": ["Involuntary psychiatric hospitalization for imminent self-harm risk", "Voluntary psychiatric hospitalization for stabilization", "Discharge with outpatient dialectical behavior therapy referral", "Discharge with outpatient psychodynamic psychotherapy referral", "23-hour observation unit placement with crisis intervention"], "answer": "C", "answer_index": 2, "explanation": "This patient presents with borderline personality disorder (BPD) with non-suicidal self-injury (NSSI). Evidence strongly supports that psychiatric hospitalization for NSSI in BPD is generally not beneficial and may be harmful by reinforcing maladaptive behaviors and disrupting outpatient treatment. Dialectical behavior therapy (DBT) is the most evidence-based treatment for BPD and specifically targets self-harm behaviors. The patient denies suicidal intent, has a pattern consistent with NSSI rather than suicide attempts, and does not meet criteria for involuntary commitment. Outpatient DBT referral with appropriate safety planning is the standard of care.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem clearly describes borderline personality disorder (BPD) with non-suicidal self-injury (NSSI): superficial cuts, chronic pattern over 3 years, intense unstable relationships, emptiness, impulsivity, and affective lability. The key discriminating factor is the patient's explicit denial of suicidal ideation combined with a chronic, repetitive pattern of NSSI rather than acute suicide attempts. Current psychiatric consensus and APA guidelines indicate that hospitalization for NSSI alone in BPD is not beneficial and may reinforce maladaptive behaviors. Dialectical behavior therapy (DBT) is the evidence-based gold-standard outpatient treatment specifically targeting self-harm and emotional dysregulation in BPD. Alternative A fails because NSSI without suicidal intent rarely meets imminent danger criteria for involuntary commitment. Alternative B is suboptimal as voluntary hospitalization similarly risks iatrogenic reinforcement. Alternative D is less effective than DBT for this presentation. Alternative E is unnecessary when direct outpatient DBT referral is feasible. The item is logically sound with distinct options permitting clear discrimination. Medical accuracy is excellent and board-relevant. No modifications required.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem clearly describes borderline personality disorder (BPD) with non-suicidal self-injury (NSSI): superficial cuts, chronic pattern over 3 years, intense unstable relationships, emptiness, impulsivity, and affective lability. The key discriminating factor is the patient's explicit denial of suicidal ideation combined with a chronic, repetitive pattern of NSSI rather than acute suicide attempts. Current psychiatric consensus and APA guidelines indicate that hospitalization for NSSI alone in BPD is not beneficial and may reinforce maladaptive behaviors. Dialectical behavior therapy (DBT) is the evidence-based gold-standard outpatient treatment specifically targeting self-harm and emotional dysregulation in BPD. Alternative A fails because NSSI without suicidal intent rarely meets imminent danger criteria for involuntary commitment. Alternative B is suboptimal as voluntary hospitalization similarly risks iatrogenic reinforcement. Alternative D is less effective than DBT for this presentation. Alternative E is unnecessary when direct outpatient DBT referral is feasible. The item is logically sound with distinct options permitting clear discrimination. Medical accuracy is excellent and board-relevant. No modifications required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-018", "question": "A 48-year-old woman undergoes total thyroidectomy for papillary thyroid carcinoma. The surgeon identifies and preserves both recurrent laryngeal nerves using intraoperative nerve monitoring. Twelve hours postoperatively, she develops progressive dyspnea, stridor, and neck swelling. Oxygen saturation is 88% on room air. The surgical site shows tense swelling with ecchymosis. Bedside flexible laryngoscopy reveals bilateral vocal cord immobility in the paramedian position with adequate glottic airway. Which of the following is the most appropriate immediate management?", "options": ["Emergent wound exploration and hematoma evacuation at bedside", "Emergent return to operating room for wound exploration", "Emergent awake tracheostomy under local anesthesia", "Emergent cricothyroidotomy", "Endotracheal intubation followed by wound exploration"], "answer": "A", "answer_index": 0, "explanation": "Post-thyroidectomy hematoma with airway compromise is a surgical emergency requiring immediate wound exploration and hematoma evacuation. When the patient has stridor and respiratory distress from neck hematoma, opening the wound at bedside (even in the absence of full surgical setup) is the fastest way to decompress the airway. This can be performed by opening skin staples/sutures and evacuating clot, which immediately relieves tracheal compression. Waiting for OR availability or attempting intubation in a patient with distorted anatomy and bilateral vocal cord paralysis risks complete airway loss. Tracheostomy and cricothyroidotomy are more invasive and time-consuming than simple wound opening.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem presents a classic post-thyroidectomy hematoma with airway compromise. Key discriminating findings include tense neck swelling with ecchymosis, stridor, and hypoxia (SpO2 88%) within 12 hours of surgery, indicating compressive tracheal obstruction. Bilateral vocal cord paralysis in paramedian position reflects recurrent laryngeal nerve edema from hematoma compression. The most appropriate immediate management is bedside wound decompression (Answer A), as this is the fastest method to relieve compression in an unstable patient. Alternative options are clearly inferior: OR exploration (B) delays life-saving decompression; awake tracheostomy (C) and cricothyroidotomy (D) are more invasive, time-consuming, and unnecessary when simple wound opening suffices; intubation (E) risks complete airway loss in distorted anatomy and bilateral cord paralysis. No logical issues or contradictions exist. Medical accuracy is sound and aligns with standard surgical emergency protocols and ATA guidelines. Minimal fix: none required; item is board-ready and appropriately discriminating.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem presents a classic post-thyroidectomy hematoma with airway compromise. Key discriminating findings include tense neck swelling with ecchymosis, stridor, and hypoxia (SpO2 88%) within 12 hours of surgery, indicating compressive tracheal obstruction. Bilateral vocal cord paralysis in paramedian position reflects recurrent laryngeal nerve edema from hematoma compression. The most appropriate immediate management is bedside wound decompression (Answer A), as this is the fastest method to relieve compression in an unstable patient. Alternative options are clearly inferior: OR exploration (B) delays life-saving decompression; awake tracheostomy (C) and cricothyroidotomy (D) are more invasive, time-consuming, and unnecessary when simple wound opening suffices; intubation (E) risks complete airway loss in distorted anatomy and bilateral cord paralysis. No logical issues or contradictions exist. Medical accuracy is sound and aligns with standard surgical emergency protocols and ATA guidelines. Minimal fix: none required; item is board-ready and appropriately discriminating.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-019", "question": "A 55-year-old man with cirrhosis secondary to hepatitis C (Child-Pugh class B, MELD score 18) presents with a 3-cm hepatocellular carcinoma in segment VI, discovered on surveillance imaging. He has no extrahepatic disease and no macrovascular invasion. Portal vein is patent. He has moderate ascites controlled with diuretics and no history of hepatic encephalopathy. Performance status is ECOG 0. The hepatology tumor board discusses treatment options. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, which of the following is the most appropriate treatment recommendation?", "options": ["Liver transplantation", "Surgical resection", "Radiofrequency ablation", "Transarterial chemoembolization", "Sorafenib"], "answer": "A", "answer_index": 0, "explanation": "This patient has BCLC stage A (early HCC) with a single tumor ≤3 cm, but with Child-Pugh B cirrhosis and portal hypertension (evidenced by ascites). According to BCLC guidelines, surgical resection is only recommended for patients with preserved liver function (Child-Pugh A) without portal hypertension. For patients with early HCC and impaired liver function, liver transplantation is the preferred treatment as it addresses both the tumor and underlying liver disease. This patient meets Milan criteria (single tumor ≤5 cm). Ablation is an alternative for non-transplant candidates. TACE is for intermediate stage, and sorafenib for advanced stage disease.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\": \"Validity: V. Verdict: Correct best answer. The stem's key discriminating features—solitary 3-cm HCC satisfying Milan criteria, Child-Pugh B cirrhosis with moderate ascites indicating portal hypertension, patent portal vein, ECOG 0, and absence of extrahepatic disease—clearly categorize this as BCLC stage A disease with compromised liver function. BCLC guidelines prioritize liver transplantation as first-line therapy for early HCC in Child-Pugh B patients, making option A defensible. Resection (B) is contraindicated with portal hypertension; radiofrequency ablation (C) is reserved for non-transplant candidates; TACE (D) and sorafenib (E) apply to intermediate and advanced stages, respectively. No logical defects: the vignette yields one best answer matching the key. Minor medical accuracy issue: the item simplifies real-world transplant evaluation and waiting list management, but this is standard for board questions. Minimal fix: explicitly state 'and is an appropriate transplant candidate' to remove any candidacy ambiguity.\",\"medical_accuracy_score\":   \"4\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The stem's key discriminating features—solitary 3-cm HCC satisfying Milan criteria, Child-Pugh B cirrhosis with moderate ascites indicating portal hypertension, patent portal vein, ECOG 0, and absence of extrahepatic disease—clearly categorize this as BCLC stage A disease with compromised liver function. BCLC guidelines prioritize liver transplantation as first-line therapy for early HCC in Child-Pugh B patients, making option A defensible. Resection (B) is contraindicated with portal hypertension; radiofrequency ablation (C) is reserved for non-transplant candidates; TACE (D) and sorafenib (E) apply to intermediate and advanced stages, respectively. No logical defects: the vignette yields one best answer matching the key. Minor medical accuracy issue: the item simplifies real-world transplant evaluation and waiting list management, but this is standard for board questions. Minimal fix: explicitly state 'and is an appropriate transplant candidate' to remove any candidacy ambiguity.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-020", "question": "A 62-year-old woman with type 2 diabetes presents with a 2-day history of severe right eye pain, redness, and decreased vision. She reports seeing halos around lights. Visual acuity is counting fingers at 2 feet OD and 20/30 OS. Examination reveals conjunctival injection, corneal edema with microcystic changes, a mid-dilated non-reactive pupil, and shallow anterior chamber OD. Intraocular pressure is 58 mmHg OD and 16 mmHg OS. Gonioscopy of the left eye shows narrow angles with appositional closure in the superior quadrant. After initial medical therapy with topical timolol, brimonidine, pilocarpine, and intravenous acetazolamide, IOP decreases to 32 mmHg at 2 hours. Corneal edema persists. Which of the following is the most appropriate definitive treatment?", "options": ["Laser peripheral iridotomy of the right eye only", "Laser peripheral iridotomy of both eyes", "Trabeculectomy of the right eye", "Phacoemulsification with intraocular lens implantation of the right eye", "Argon laser trabeculoplasty of the right eye"], "answer": "B", "answer_index": 1, "explanation": "This patient has acute primary angle-closure glaucoma (APACG). Laser peripheral iridotomy (LPI) is the definitive treatment as it creates an alternative pathway for aqueous flow, relieving pupillary block. Critically, LPI must be performed on BOTH eyes because angle-closure is a bilateral anatomical predisposition-the fellow eye has a 40-80% risk of developing acute angle closure if left untreated, as evidenced by the narrow angles with appositional closure seen on gonioscopy OS. Trabeculectomy is reserved for cases with persistent IOP elevation after LPI. Phacoemulsification may be considered later but is not first-line. Argon laser trabeculoplasty is contraindicated in angle closure.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. This acute primary angle-closure glaucoma (APACG) item presents a classic unilateral acute attack with confirmed high-risk anatomy in the fellow eye (narrow angles with appositional closure). The question asks for the 'most appropriate definitive treatment.' Key discriminating findings include: mid-dilated non-reactive pupil, shallow anterior chamber, IOP 58 mmHg OD, and gonioscopic evidence of appositional closure OS despite normal IOP. Laser peripheral iridotomy (LPI) is the definitive treatment for pupillary-block angle closure. The provided key (B: LPI of both eyes) is correct and defensible as the single best answer because: (1) LPI directly addresses the underlying pupillary block mechanism; (2) bilateral treatment is mandatory when the fellow eye demonstrates high-risk anatomy, with 40-80% risk of subsequent attack; (3) alternatives are clearly inferior—unilateral LPI (A) neglects established fellow-eye risk, trabeculectomy (C) is reserved for LPI failure, phacoemulsification (D) is not first-line definitive therapy, and ALT (E) is contraindicated in angle closure. The persistent corneal edema does not invalidate LPI as the definitive treatment; it merely delays timing. No logical flaws or medical inaccuracies are present. Minimal fix: None required.\",\"medical_accuracy_score\":   \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. This acute primary angle-closure glaucoma (APACG) item presents a classic unilateral acute attack with confirmed high-risk anatomy in the fellow eye (narrow angles with appositional closure). The question asks for the 'most appropriate definitive treatment.' Key discriminating findings include: mid-dilated non-reactive pupil, shallow anterior chamber, IOP 58 mmHg OD, and gonioscopic evidence of appositional closure OS despite normal IOP. Laser peripheral iridotomy (LPI) is the definitive treatment for pupillary-block angle closure. The provided key (B: LPI of both eyes) is correct and defensible as the single best answer because: (1) LPI directly addresses the underlying pupillary block mechanism; (2) bilateral treatment is mandatory when the fellow eye demonstrates high-risk anatomy, with 40-80% risk of subsequent attack; (3) alternatives are clearly inferior—unilateral LPI (A) neglects established fellow-eye risk, trabeculectomy (C) is reserved for LPI failure, phacoemulsification (D) is not first-line definitive therapy, and ALT (E) is contraindicated in angle closure. The persistent corneal edema does not invalidate LPI as the definitive treatment; it merely delays timing. No logical flaws or medical inaccuracies are present. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]